During the past decade, IRCCS Fondazione Stella Maris conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 2 clinical trials were completed, i.e. on average, 9.1% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "IRCCS Fondazione Stella Maris" #1 sponsor was "IRCCS Fondazione Stella Maris" with 16 trials, followed by "Institut de Recherches Internationales Servier" with 2 trials sponsored, "Shire" with 2 trials sponsored, "University of Pisa" with 2 trials sponsored and "Dr. Rebecca Schule" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "IRCCS Fondazione Stella Maris" #1 collaborator was "Ministry of Health, Italy" with 4 trials as a collaborator, "University of Pisa" with 4 trials as a collaborator, "IRCCS Fondazione Stella Maris" with 3 trials as a collaborator, "ADIR, a Servier Group company" with 2 trials as a collaborator and "Azienda Ospedaliero, Universitaria Pisana" with 2 trials as a collaborator. Other collaborators include 18 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "IRCCS Fondazione Stella Maris" are "Cerebral Palsy" (6 trials), "Hemiplegia" (3 trials), "Hemiplegic Cerebral Palsy" (3 trials), "Autism Spectrum Disorder (ASD)" (2 trials) and "Premature Birth" (2 trials). Many other conditions were trialed in "IRCCS Fondazione Stella Maris" in a lesser frequency.

Most popular intervention types in "IRCCS Fondazione Stella Maris" are "Other" (10 trials), "Behavioral" (6 trials), "Drug" (5 trials), "Device" (3 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "AOT" (1 trials), "Actigraph" (1 trials), "BUMETANIDE/S95008" (1 trials) and "Bumetanide Oral Solution" (1 trials). Other intervention names were less common.

The vast majority of trials in "IRCCS Fondazione Stella Maris" are 25 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are 9 active trials in "IRCCS Fondazione Stella Maris". 1 are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 15 completed trials in IRCCS Fondazione Stella Maris, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in IRCCS Fondazione Stella Maris, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 14 trials that are defined as “Not Applicable".